CAMBRIDGE, Mass. (AP) _ Infinity Pharmaceuticals Inc. (INFI) on Tuesday reported a loss of $13.7 million in its first quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 24 cents.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 5 cents per share.
The drugmaker posted revenue of $2.1 million in the period.
In the final minutes of trading on Tuesday, the company's shares hit $1.73. A year ago, they were trading at $2.20.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INFI at https://www.zacks.com/ap/INFI